Abiopharma

🔍 MOYER BRETT (Director)

Company: Datavault AI Inc. (DVLT)

Report Date: 2026-08-18

Detailed Transactions and Holdings:

• Acquired 26,024 shares of Common Stock (Direct)
  Date: 2026-08-18 | Code: A | equity_swap_involved: 0 | shares_owned_after: 5,560,536.00 | transaction_form_type: 4 | Footnotes: F1, F1

Footnotes:

• F1: Received in exchange for 18,413 shares of NYIAX, Inc. ("NYIAX") common stock in connection with the merger of NYIAX with and into DVLT Merger Sub Inc., a wholly owned subsidiary of the Issuer ("Merger Sub"), pursuant to that certain Agreement and Plan of Merger, dated as of March 18, 2026, as amended from time to time (the "Merger Agreement"), by and among the Issuer, Merger Sub and NYIAX. At the effective time of the merger contemplated by the Merger Agreement, the Reporting Person, as a stockholder of NYIAX, became entitled to receive a number of shares of the Issuer's common stock equal to the exchange ratio (determined pursuant to the Merger Agreement) for each share of NYIAX common stock held by the Reporting Person. The exchange ratio was approximately 1.41 shares of Issuer common stock for each share of NYIAX common stock.